ECG Q1 2026 Earnings Call Summary | Stock Taper
Logo
ECG

ECG — Everus Construction Group, Inc.

NYSE


Q1 2026 Earnings Call Summary

May 6, 2026

Everus Construction Group, Inc. (ECG) Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

  • Revenues: $1.04 billion, up 25% year-over-year.
  • EBITDA: $88.9 million, a 44% increase from Q1 2025, resulting in an EBITDA margin of 8.6%, up 110 basis points.
  • Backlog: $3.68 billion, a 20% increase from the previous year, with notable growth in both E and M (Electrical and Mechanical) and T and D (Transmission and Distribution) segments.
  • Operating Cash Flow: $143.7 million, significantly improved from $7.1 million in the prior year.
  • Free Cash Flow: $131.9 million, up from a cash use of $8.1 million in 2025.
  • Net Leverage: Pro forma net leverage at approximately 0.5 times post-acquisition of SCNM.

2. Strategic Updates and Business Highlights

  • Acquisition: Successful acquisition of SCNM, enhancing ECG's footprint in the Southeast U.S. and diversifying its service offerings, particularly in pharma and healthcare.
  • Market Trends: Strong demand in diverse markets, particularly data centers, hospitality, and utilities, contributing to backlog growth.
  • Operational Excellence: Continued focus on disciplined project selection and execution, maintaining a balanced mix of fixed-price and cost-plus contracts to manage risk and margin stability.

3. Forward Guidance and Outlook

  • 2026 Revenue Guidance: Raised to a range of $4.3 billion to $4.4 billion.
  • EBITDA Guidance: Expected in the range of $345 million to $360 million, with EBITDA margins anticipated around 8.1%.
  • Seasonality: No significant seasonal dip expected; the company anticipates a more stable revenue pattern throughout the year.

4. Challenges and Points of Concern

  • Labor Availability: Ongoing challenges in sourcing qualified labor could constrain growth, despite current strong employment levels.
  • Market Competition: The competitive landscape remains steady, which could pressure margins and project selection.
  • Guidance Caution: While the company raised guidance, management expressed caution regarding the timing of project completions and potential normalization of cash flow in future quarters.

5. Notable Q&A Insights

  • Geographic Expansion: Management indicated optimism about securing additional awards in new geographies, particularly with a high-tech client.
  • Payment Terms: Improved payment terms have positively impacted cash flow, but management noted that the strong cash quarter was largely due to timing rather than a consistent trend.
  • Contract Mix: The company plans to maintain a balanced approach between fixed-price and cost-plus contracts to manage risks effectively.
  • Integration of SCNM: Integration is progressing well, and SCNM is expected to contribute significantly to revenue and EBITDA margins in 2026.

Overall, ECG reported a strong start to 2026, driven by robust revenue growth and strategic acquisitions, while also highlighting potential challenges in labor availability and market competition.